By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market Monday that its third-quarter revenues increased 17 percent year over year, and the firm posted a profit for the second quarter in a row.

The Redwood City, Calif.-based pharmacogenomic test maker brought in total revenues of $46.3 million, compared to revenues of $39.5 million for the third quarter of 2009. It beat analysts' consensus estimate of $44.9 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.